Kingstown Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$22K Sell
50,000
-110,821
-69% -$65.4K 0.07% 16
2022
Q2
$77K Hold
160,821
0.13% 22
2022
Q1
$98K Buy
+160,821
New +$87.7K 0.15% 26

Other funds holding DRTSW

Kingstown Capital Management's DRTSW Position: Q3 2022 in Review

Kingstown Capital Management reduced its Alpha Tau Medical Warrant (DRTSW) stake by 69% in Q3 2022, selling an estimated $65.4K and leaving 50,000 shares worth $22K. The position accounts for 0.07% of the portfolio, ranked #16.

Kingstown Capital Management first reported a position in DRTSW in Q1 2022 and has held it in 3 quarters since. The position peaked at $98K in Q1 2022. 38 funds tracked by Wall St. Rank hold DRTSW as of Q3 2022.

  • Kingstown Capital Management held 50,000 shares of Alpha Tau Medical Warrant worth $22K as of Q3 2022.
  • Kingstown Capital Management sold 110,821 Alpha Tau Medical Warrant shares in Q3 2022, an estimated $65.4K.
  • Alpha Tau Medical Warrant made up 0.07% of Kingstown Capital Management's portfolio in Q3 2022, its #16 holding.
  • Kingstown Capital Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and has held it in 3 quarters since.
  • Kingstown Capital Management's Alpha Tau Medical Warrant position peaked at $98K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q3 2022.

Based on Kingstown Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.